3 completed, 1 unknown. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow Tinnitus, Subjective: new trials by email Literature Review of Tinnitus, Subjective trials Research Report on Tinnitus, Subjective
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Combined Antioxidant Therapy on Oxidative Stress Markers and Inflammatory Cytokines in Patients With Tinnitus Drusen Mega®, Sertraline, Placebo - Tinnitus, Subjective, Tinnitus, Bilateral | Phase 2 | Unknown | University of Guadalajara | 58 | 2022-12-01 | 2023-04-07 |
| OTO-313 in Subjects With Subjective Tinnitus OTO-313, Placebo - Tinnitus, Subjective | Phase 1 / Phase 2 | Completed | Otonomy, Inc. | 43 | 2019-04-04 | 2022-12-23 |
| Evaluating Possible Improvement in Tinnitus Severity After 28 Days Dosing of the Study Drug AUT00063 Compared to Placebo AUT00063, Placebo - Tinnitus, Subjective | Phase 2 | Completed | Autifony Therapeutics Limited | 91 | 2014-10-01 | 2016-03-31 |
| Sulodexide Efficacy in Chronic Idiopathic Subjective Tinnitus Sulodexide, Placebo - Tinnitus, Subjective | Phase 2 | Completed | St Joseph University, Beirut, Lebanon | 126 | 2014-08-01 | 2017-09-14 |
Tinnitus (4)
Ear Diseases (4) · Hearing Disorders (4) · Nervous System Diseases (4) · Neurologic Manifestations (4) · Otorhinolaryngologic Diseases (4) · Pathological Conditions, Signs and Symptoms (4) · Sensation Disorders (4) · Signs and Symptoms (4)
AUT00063 (1) · Geritol (1) · Magnesium Oxide (1) · Sertraline (1) · glucuronyl glucosamine glycan sulfate (1)
Autifony Therapeutics Limited (1) · Otonomy, Inc. (1) · St Joseph University, Beirut, Lebanon (1) · University of Guadalajara (1)
Lebanon (1) · Mexico (1) · United Kingdom (1) · United States (1)
Elias Eter, MD (1) · Jaydip Ray, MD (1)